Brokers Issue Forecasts for Xeris Biopharma FY2025 Earnings
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Free Report) – Analysts at Leerink Partnrs issued their FY2025 earnings per share estimates for shares of Xeris Biopharma in a research note issued to investors on Wednesday, June 4th. Leerink Partnrs analyst R. Ruiz anticipates that the company will earn ($0.05) per share for the year. The consensus […]
